Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Foundation for Research in Genetics and Endocrinology, |
RCV003322942 | SCV004027839 | uncertain significance | Spinocerebellar ataxia type 40 | 2023-08-17 | criteria provided, single submitter | clinical testing | The identified heterozygous missense substitution (p.Glu247Lys) lies in exon 8 of the CCDC88C gene and alters a conserved residue in the protein. The identified variant has been reported in the dbSNP and gnomAD databases with MAF of 0.006%. The in silico prediction of the variant is damaging by Mutation Assessor, Mutation Taster and SIFT. In summary, the variant meets our criteria to be classified as variant of uncertain significance. |
Ambry Genetics | RCV004334069 | SCV004922676 | uncertain significance | Inborn genetic diseases | 2021-01-27 | criteria provided, single submitter | clinical testing | The c.739G>A (p.E247K) alteration is located in exon 8 (coding exon 8) of the CCDC88C gene. This alteration results from a G to A substitution at nucleotide position 739, causing the glutamic acid (E) at amino acid position 247 to be replaced by a lysine (K). The p.E247K alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005012870 | SCV005637721 | uncertain significance | Hydrocephalus, nonsyndromic, autosomal recessive 1; Spinocerebellar ataxia type 40 | 2024-02-22 | criteria provided, single submitter | clinical testing |